73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
29.05. - 01.06.2022, Köln
Vorträge Mittwoch, 01.06.2022
Experimentelle Neuroonkologie III/Experimental neurooncology III
Meeting Abstract
(V280)
[Full Text]
Ex vivo glioblastoma organoids reflect the intertumoral heterogeneity of the parental tumour
Trautmann L, Diener L, Goedert N, Schulz E, Monoranu CM, Ernestus RI, Hagemann C, Löhr M, Dufner V[Full Text]
Meeting Abstract
(V281)
[Full Text]
Development of selective nanoparticles for p53-replacement therapy for gliomas
Jugel W, Broghammer F, Michen S, Schackert G, Temme A[Full Text]
Meeting Abstract
(V282)
[Full Text]
Metabotropic glutamate receptor III inhibition sensitises GBM to chemotherapeutics
Joseph K, Maier J, Ravi VM, Beck J, Hofmann U, Heiland DH, Schnell O[Full Text]
Meeting Abstract
(V283)
[Full Text]
CMV infection in glioblastoma leads to shortened overall survival and TMZ resistance in vitro and in vivo
Krenzlin H, Tabatabaei E, Corr F, Ringel F, Keric N[Full Text]
Meeting Abstract
(V284)
[Full Text]
Spatial T-cell receptor sequencing (SPTCR-seq) uncovers regional anti-tumour immunity in glioblastoma
Kada Benotmane J, Kückelhaus J, Will P, Schnell O, Beck J, Ravi VM, Joseph K, Heiland DH[Full Text]
Meeting Abstract
(V285)
[Full Text]
Regulation of the receptor tyrosine kinase AXL in response to therapy and its role in therapy resistance in glioblastoma
Karbe AG, Scherschinski L, Prem M, Kremenetskaia I, Tinhofer I, Vajkoczy P, Onken JS[Full Text]